PegBio, a Hangzhou-headquartered Chinese language biotech agency, made its debut on the principle board of the Hong Kong Inventory Trade (HKEX) on Might 27. The inventory opened at HK$13.5 ($1.7) per share, 13.5% decrease than the itemizing worth of HK$15.6, which positioned the preliminary public providing (IPO) supply at HK$300.8 million in complete dimension.
¬ Haymarket Media Restricted. All rights reserved.